PRESS RELEASEAB SCIENCE RECEIVES JAPANESE PATENT PROTECTION FOR THE USE OF MASITINIB IN PROGRESSIVE FORMS OF MULTIPLE SCLEROSIS (MS) UNTIL ...

Foralumab stabilized disability for 6 months in all 10 people with nonactive SPMS who took part in an expanded access program, a study found.

Olatec Therapeutics, Inc. ("Olatec"), a clinical stage biotechnology company leading the development of specific NLRP3 inhibitors, presented preclinical data at The Michael J. Fox Foundation (MJFF) ...

By Vijay Kumar Malesu New mouse data reveal that ageing neurons struggle to clear synaptic proteins, shifting the burden to ...

For a long time, neuroscientists treated this forgetting as a cognitive glitch or a simple lack of brainware maturity. But a ...

This revised study describes an important new model for in vivo manipulation of microglia, exploring how mutations in the Adar1 gene within microglia contribute to Aicardi-Goutières Syndome. The ...

According to the data, when microglia activity in the brain was suppressed, baby mice were better able to recall fearful experiences.

Scientists have found that blocking microglia (specialist immune cells in the brain) prevents infant forgetting ("infantile amnesia") and improves memory in mice, suggesting that microglia may ...

A comprehensive new review is shedding light on the growing evidence that gut microbiome imbalances—known as dysbiosis—may ...

Brain-meningeal immunity is increasingly recognized as a central player in the complex network of interactions within the central nervous system (CNS).

For a long time, the study of the brain has largely focused on neuronal cells. However, neurons develop and interact closely together in space and time with ...